Showing results (211-220 of 221) with videos related to
Sort By:
Pageof 23
European Journal of Nuclear Medicine and Molecular Imaging|March 7, 2021
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkersN J Ashton, A Leuzy, T K Karikari, et al.Chemico-Biological Interactions|July 29, 1998
An evolutionary approach to the design of glutathione-linked enzymesB Mannervik, A D Cameron, E Fernandez, et al.The Journal of Prevention of Alzheimer'S Disease|June 25, 2023
Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task ForceD Angioni, O Hansson, R J Bateman, et al.The Journal of Nutrition, Health & Aging|March 6, 2009
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessmentK Blennow, G De Meyer, O Hansson, et al.Nature Medicine|July 9, 2026
Human embryonic stem cell-derived dopaminergic cells for Parkinson's disease: a phase 1/2 open-label trialG Paul, H Bjartmarz, A Kirkeby, et al.The Journal of Prevention of Alzheimer'S Disease|March 22, 2023
Investigating Partially Discordant Results in Phase 3 Studies of AducanumabC Mallinckrodt, Y Tian, P S Aisen, et al.The Journal of Prevention of Alzheimer'S Disease|May 11, 2022
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's DiseaseS Budd Haeberlein, P S Aisen, F Barkhof, et al.The Journal of Prevention of Alzheimer'S Disease|October 25, 2022
Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task ForceD Angioni, J Delrieu, O Hansson, et al.The Journal of Prevention of Alzheimer'S Disease|February 20, 2024
Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer's Disease Detection and Dementia Risk Reduction: The AD-RIDDLE ProjectK Malzbender, P Barbarino, P Barkman Ferrell, et al.Neurology|February 4, 2012
Age and diagnostic performance of Alzheimer disease CSF biomarkersN Mattsson, E Rosén, O Hansson, et al.Pageof 23